p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis
Open Access
- 1 November 1995
- journal article
- Published by Elsevier in Human Pathology
- Vol. 26 (11), 1268-1274
- https://doi.org/10.1016/0046-8177(95)90204-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinomaGynecologic Oncology, 1992
- Assessment of the Risk on Endometrial Cancer in Hyperplasia, by Means of Morphological and Morphometrical FeaturesPathology - Research and Practice, 1992
- Uterine Papillary Serous CarcinomaObstetrical & Gynecological Survey, 1991
- Analysis of oncogene alterations in human endometrial carcinoma: Prevalence of ras mutationsMolecular Carcinogenesis, 1991
- The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the UterusThe American Journal of Surgical Pathology, 1990
- Papillary Serous Adenocarcinoma of the EndometriumObstetrics & Gynecology, 1986
- Endometrial Papillary AdenocarcinomasInternational Journal of Gynecological Pathology, 1985
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981